PTEN and neoplasm: Somatic PTEN mutations and deletions or epigenetic silencing are common in multiple tumor types, including breast, endometrium, and thyroid, but also tumors of central nervous system, prostate, lung, melanoma, leukemia and lymphoma [3]–[11].